Cargando…

Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome with underlying history of malignancy

KEY CLINICAL MESSAGE: By reporting this case, we hope to emphasize the importance of maintaining a high index of clinical suspicion for the early recognition of RS3PE in patients presenting with atypical symptoms of PMR and underlying history of malignancy. ABSTRACT: Remitting seronegative symmetric...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kain, Marvil, Charles, Adhyaru, Bhavin B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167620/
https://www.ncbi.nlm.nih.gov/pubmed/37180322
http://dx.doi.org/10.1002/ccr3.7330
Descripción
Sumario:KEY CLINICAL MESSAGE: By reporting this case, we hope to emphasize the importance of maintaining a high index of clinical suspicion for the early recognition of RS3PE in patients presenting with atypical symptoms of PMR and underlying history of malignancy. ABSTRACT: Remitting seronegative symmetrical synovitis with pitting edema is a rare rheumatic syndrome of unknown etiology. It shares qualities with many other common rheumatological disorders such as rheumatoid arthritis and polymyalgia rheumatica, making diagnosis especially challenging. RS3PE has been speculated to be a paraneoplastic syndrome, and those cases associated with underlying malignancy have shown to respond poorly to conventional treatment. Therefore, it is advisable to routinely screen patients with malignancy and presenting with RS3PE for cancer recurrence, even if in remission.